Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayana Moore

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Trials|June 27, 2023
Predictors of participant retention in a community-based HIV prevention cohort: perspectives from the HPTN 071 (PopART) studyNomtha Bell-Mandla, Ethan Wilson, Deeksha Sharma, et al.
Journal of the International AIDS Society|December 13, 2021
Validation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trialEthan Klock, Ethan Wilson, Reinaldo E Fernandez, et al.
The Lancet. HIV|November 4, 2022
Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trialEthan Wilson, Deborah Donnell, Timothy Skalland, et al.
PLOS Global Public Health|June 1, 2026
Migration and its impact on universal HIV testing and treatment in the HPTN 071 (PopART) study communitiesDavid Macleod, Sian Floyd, Kwame Shanaube, et al.
Journal of the International AIDS Society|October 27, 2023
Population-level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART)Wendy Grant-McAuley, Estelle Piwowar-Manning, William Clarke, et al.
Open Forum Infectious Diseases|November 30, 2022
Antiretroviral Drug Detection in a Community-Randomized Trial of Universal HIV Testing and Treatment: HPTN 071 (PopART)Jessica M Fogel, Kidist Zewdie, William A Clarke, et al.
Plos One|December 17, 2021
Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART)Wendy Grant-McAuley, Ethan Klock, Oliver Laeyendecker, et al.
The Lancet. HIV|November 4, 2022
Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysisDavid Macleod, Kwame Shanaube, Timothy Skalland, et al.
Journal of the International AIDS Society|July 1, 2022
HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART)Jessica M Fogel, Ethan A Wilson, Estelle Piwowar-Manning, et al.
Journal of the International AIDS Society|February 20, 2020
Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART)Susan H Eshleman, Estelle Piwowar-Manning, Ethan A Wilson, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Trials|June 27, 2023
Predictors of participant retention in a community-based HIV prevention cohort: perspectives from the HPTN 071 (PopART) studyNomtha Bell-Mandla, Ethan Wilson, Deeksha Sharma, et al.
Journal of the International AIDS Society|December 13, 2021
Validation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trialEthan Klock, Ethan Wilson, Reinaldo E Fernandez, et al.
The Lancet. HIV|November 4, 2022
Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trialEthan Wilson, Deborah Donnell, Timothy Skalland, et al.
PLOS Global Public Health|June 1, 2026
Migration and its impact on universal HIV testing and treatment in the HPTN 071 (PopART) study communitiesDavid Macleod, Sian Floyd, Kwame Shanaube, et al.
Journal of the International AIDS Society|October 27, 2023
Population-level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART)Wendy Grant-McAuley, Estelle Piwowar-Manning, William Clarke, et al.
Open Forum Infectious Diseases|November 30, 2022
Antiretroviral Drug Detection in a Community-Randomized Trial of Universal HIV Testing and Treatment: HPTN 071 (PopART)Jessica M Fogel, Kidist Zewdie, William A Clarke, et al.
Plos One|December 17, 2021
Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART)Wendy Grant-McAuley, Ethan Klock, Oliver Laeyendecker, et al.
The Lancet. HIV|November 4, 2022
Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysisDavid Macleod, Kwame Shanaube, Timothy Skalland, et al.
Journal of the International AIDS Society|July 1, 2022
HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART)Jessica M Fogel, Ethan A Wilson, Estelle Piwowar-Manning, et al.
Journal of the International AIDS Society|February 20, 2020
Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART)Susan H Eshleman, Estelle Piwowar-Manning, Ethan A Wilson, et al.
Pageof 3